Form 4: Cognizant Director Leo S. Mackay Jr. Reports Acquisition of Additional Stock Units Through Dividend Equivalents

Sentiment:

Insider Transaction Report


Cognizant Technology Solutions Corp. Director Leo S. Mackay Jr. reported the acquisition of additional deferred and restricted stock units on May 28, 2025, through dividend equivalent rights.

Summary

  • Leo S. Mackay Jr., a Director at Cognizant Technology Solutions Corp. (CTSH), reported changes in his beneficial ownership of company securities.
  • On May 28, 2025, Mr. Mackay acquired 17.7777 Deferred Restricted Stock Units (DRSUs) and 13.1158 Restricted Stock Units (RSUs).
  • These acquisitions were due to dividend equivalent rights accrued on previously outstanding deferred and restricted stock units.
  • Each unit represents a right to receive one share of Cognizant's Class A Common Stock.
  • Following these transactions, Mr. Mackay beneficially owns 4,632.0066 Deferred Restricted Stock Units and 3,417.301 Restricted Stock Units.
  • The Deferred Restricted Stock Units are fully vested and will be settled upon Mr. Mackay's termination of service from the Board.
  • The Restricted Stock Units will vest fully on June 4, 2025, with settlement deferred until the first to occur of a change in control, death or permanent disability, or the first July 1 following termination of service.

Sentiment

Score: 5

Explanation: The filing is a routine insider transaction report for dividend equivalent rights, indicating a neutral impact on company sentiment. It reflects standard compensation practices rather than significant operational or financial news.

Positives

  • The acquisition of additional stock units by a director through dividend equivalent rights indicates continued participation in the company's equity program.
  • The deferred settlement of RSUs until termination of service or specific events aligns the director's long-term interests with shareholder value.

Future Outlook

This Form 4 filing primarily reports past transactions and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is a routine insider transaction report for a director of a major IT services company. It reflects standard compensation practices for non-employee directors, where equity awards often include dividend equivalent rights to ensure directors benefit from dividends paid on underlying shares before vesting or settlement.

Comparison to Industry Standards

  • The practice of granting restricted stock units and deferred restricted stock units, along with dividend equivalent rights, is a common compensation mechanism for non-employee directors in large publicly traded companies, particularly within the technology and IT services sectors.
  • This aligns director incentives with long-term shareholder value, which is a standard corporate governance practice across global benchmarks.

Stakeholder Impact

  • Shareholders: The transaction is a routine part of director compensation and has a minimal direct impact on existing shareholders, primarily reflecting the ongoing equity alignment of a director.

Key Dates

DateDescription
05/28/2025Transaction date for the acquisition of Deferred Restricted Stock Units and Restricted Stock Units.
05/30/2025Date the Form 4 was signed.
06/04/2025Vesting date for the newly acquired Restricted Stock Units.

Recommendation

hold

Keywords

Cognizant Technology Solutions, CTSH, Form 4, Insider Transaction, Beneficial Ownership, Restricted Stock Units, Deferred Restricted Stock Units, Director Compensation, Dividend Equivalent Rights

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.